Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia

NCT05895500 · clinicaltrials.gov ↗

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye
Asthenopia

Interventions

DRUG: Injection for SC administration (120mg/syringe)
DRUG: Tablet (50mg/tablet), oral

Sponsor

Nvision Laser Eye Centers